Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.
Authors: Matossian MD; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., Hoang VT; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., Burks HE; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., La J; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., Elliott S; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA., Brock C; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA., Rusch DB; Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN 47405, USA., Buechlein A; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN 47405, USA., Nephew KP; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN 47405, USA., Bhatt A; Department of Pharmacology, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA., Cavanaugh JE; Department of Pharmacology, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA., Flaherty PT; Department of Medicinal Chemistry, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA., Collins-Burow BM; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; Tulane Cancer Center, New Orleans, LA 70112, USA., Burow ME; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.
Source: Oncoscience [Oncoscience] 2021 May 18; Vol. 8, pp. 64-71. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals LLC Country of Publication: United States NLM ID: 101636666 Publication Model: eCollection Cited Medium: Print ISSN: 2331-4737 (Print) Linking ISSN: 23314737 NLM ISO Abbreviation: Oncoscience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2331-4737
DOI:10.18632/oncoscience.535